Home / Health / Covid-19: AIIMS to start human clinical trial of Covaxin from Monday

Covid-19: AIIMS to start human clinical trial of Covaxin from Monday

Covaxin is being tested in 12 places, according to the Indian Council for Medical Research.

Premium

Trials have started at AIIMS, Patna and few other places.

3 min read Last Updated : Jul 19 2020 | 7:56 AM IST

The All India Institute of Medical Sciences (AIIMS) will from Monday conduct human clinical trials of the indigenously developed Covid-19 vaccine candidate Covaxin, said a senior doctor of the Delhi hospital.

Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS told news ageny ANI, an ethics committee had approved the trials.

"Today, we got approval from AIIMS Ethics Committee for starting the human clinical trial of the indigenously developed Covaxin. We are launching the enrollment process from Monday. We are going to select healthy participants with no comorbidities and without a history of Covid-19. The age group of the

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in